Current developments and future directions in COPD

Alexander G Mathioudakis; Lowie E G W Vanfleteren; Lies Lahousse; Andrew Higham; James P Allinson; Carolina Gotera; Dina Visca; Dave Singh; Antonio Spanevello

doi:10.1183/16000617.0289-2020

Current developments and future directions in COPD

Eur Respir Rev. 2020 Dec 2;29(158):200289. doi: 10.1183/16000617.0289-2020. Print 2020 Dec 31.

Authors

Alexander G Mathioudakis^{1

2}, Lowie E G W Vanfleteren³, Lies Lahousse⁴, Andrew Higham^{5

2}, James P Allinson⁶, Carolina Gotera⁷, Dina Visca^{8

9}, Dave Singh^{5

2

10}, Antonio Spanevello^{8

9}

Affiliations

¹ Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, The University of Manchester, Manchester, UK alexander.mathioudakis@Manchester.ac.uk.
² North West Lung Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
³ COPD Center, Institute of Medicine, Sahlgrenska University Hospital, University of Gothenburg, Gothenburg, Sweden.
⁴ Dept of Bioanalysis, Pharmaceutical Care Unit, Ghent University, Ghent, Belgium.
⁵ Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, The University of Manchester, Manchester, UK.
⁶ The Royal Brompton Hospital and The National Heart and Lung Institute, Imperial College London, London, UK.
⁷ Dept of Pneumology, IIS-Fundación Jiménez Díaz, ISCIII-CIBERES, Madrid, Spain.
⁸ Division of Pulmonary Rehabilitation, Istituti Clinici Scientifici Maugeri, IRCCS, Tradate, Italy.
⁹ Dept of Medicine and Surgery, Respiratory Diseases, University of Insubria, Varese-Como, Italy.
¹⁰ Medicines Evaluation Unit, Manchester, UK.

Abstract

The European Respiratory Society journals publish respiratory research and policy documents of the highest quality, offering a platform for the exchange and promotion of scientific knowledge. In this article, focusing on COPD, the third leading cause of death globally, we summarise novel research highlights focusing on the disease's underlying mechanisms, epidemiology and management, with the aim to inform and inspire respiratory clinicians and researchers.

MeSH terms

Humans
Pulmonary Disease, Chronic Obstructive* / diagnosis
Pulmonary Disease, Chronic Obstructive* / epidemiology
Pulmonary Disease, Chronic Obstructive* / therapy